At close: 4:00 PM EST
After hours: 6:19 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,315.0000
--
691.0000
160.0000
43.8200
Cost of Revenue
1,398.0000
--
1,332.0000
55.0000
18.2570
Gross Profit
1,917.0000
--
-641.0000
105.0000
25.5630
Operating Expense
15,651.0000
--
18,084.0000
6,566.0000
561.8520
Operating Income
-13,734.0000
--
-18,725.0000
-6,461.0000
-536.2890
Net Non Operating Interest Income Expense
-51.0000
--
-354.0000
-621.0000
-167.8460
Other Income Expense
65.0000
--
162.0000
1.0000
-1.2300
Pretax Income
-13,720.0000
--
-18,917.0000
-7,081.0000
-705.3650
Net Income Common Stockholders
-13,720.0000
--
-18,917.0000
-7,048.0000
-585.1780
Diluted NI Available to Com Stockholders
-13,720.0000
--
-18,917.0000
-7,048.0000
-585.1780
Basic EPS
287.92
-68.72
-188.96
-50.18
-4.17
Diluted EPS
287.92
-68.72
-188.96
-50.18
-4.17
Basic Average Shares
261.6250
226.7500
100.1250
140.4600
140.4600
Diluted Average Shares
261.6250
226.7500
100.1250
140.4600
140.4600
Total Operating Income as Reported
-13,734.0000
--
-18,725.0000
-6,461.0000
-536.2890
Total Expenses
17,049.0000
--
19,416.0000
6,621.0000
580.1090
Net Income from Continuing & Discontinued Operation
-13,720.0000
--
-18,917.0000
-7,048.0000
-585.1780
Normalized Income
-13,841.0000
--
-19,097.0000
-7,050.0000
-585.1780
Interest Expense
51.0000
--
354.0000
621.0000
167.8460
Net Interest Income
-51.0000
--
-354.0000
-621.0000
-167.8460
EBIT
-13,669.0000
--
-18,563.0000
-6,460.0000
-537.5190
EBITDA
-13,044.0000
--
-18,274.0000
-6,346.0000
-537.5190
Reconciled Cost of Revenue
1,398.0000
--
1,332.0000
55.0000
18.2570
Reconciled Depreciation
625.0000
--
289.0000
114.0000
--
Net Income from Continuing Operation Net Minority Interest
-13,720.0000
--
-18,917.0000
-7,048.0000
-585.1780
Total Unusual Items Excluding Goodwill
121.0000
--
180.0000
2.0000
--
Total Unusual Items
121.0000
--
180.0000
2.0000
--
Normalized EBITDA
-13,165.0000
--
-18,454.0000
-6,348.0000
-537.5190
Tax Rate for Calcs
--
--
--
--
0.0000
12/31/2020 - 4/27/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TIVC Tivic Health Systems, Inc.
0.2422
-2.69%
INBS Intelligent Bio Solutions Inc.
1.6400
+17.14%
BBLG Bone Biologics Corporation
1.2300
-2.38%
SINT Sintx Technologies, Inc.
4.3000
+15.59%
NUWE Nuwellis, Inc.
1.2400
-4.62%
HSCS HeartSciences Inc.
2.6200
-0.76%
BJDX Bluejay Diagnostics, Inc.
3.5000
+1.74%
AMIX Autonomix Medical, Inc.
13.52
+1.20%
RSLS ReShape Lifesciences Inc.
5.58
+10.71%
VVOS Vivos Therapeutics, Inc.
2.9500
+2.08%